Company profile for Tenax Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We intend to identify and acquire innovative proprietary pharmaceutical products that represent high value commercial opportunities for the North American market. We do not intend to conduct basic research ourselves. The relative efficiency of our “search” strategy enables us to focus the majority of our resources on developing and commercializing innovative products that other companies have discovered. We intend to devel...
We intend to identify and acquire innovative proprietary pharmaceutical products that represent high value commercial opportunities for the North American market. We do not intend to conduct basic research ourselves. The relative efficiency of our “search” strategy enables us to focus the majority of our resources on developing and commercializing innovative products that other companies have discovered. We intend to develop pharmaceutical products that meet significant unmet needs in North America.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
ONE Copley Parkway, Suite 490, Morrisville, NC 27560
Telephone
Telephone
(919) 855-2100
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/25/3194188/12401/en/Tenax-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
25 Nov 2025

https://www.globenewswire.com/news-release/2025/11/12/3186761/12401/en/Tenax-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
12 Nov 2025

https://www.globenewswire.com/news-release/2025/09/16/3150630/12401/en/Tenax-Therapeutics-Announces-European-Patent-Office-Intention-to-Grant-Patent-Covering-Use-of-Levosimendan-in-PH-HFpEF.html

GLOBENEWSWIRE
16 Sep 2025

https://www.globenewswire.com/news-release/2025/08/28/3140655/12401/en/Tenax-Therapeutics-to-Participate-in-the-Cantor-Global-Healthcare-Conference-2025.html

GLOBENEWSWIRE
28 Aug 2025

https://www.globenewswire.com/news-release/2025/08/13/3132961/12401/en/Tenax-Therapeutics-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
13 Aug 2025

https://www.globenewswire.com/news-release/2025/05/14/3081576/12401/en/Tenax-Therapeutics-Reports-First-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
14 May 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty